Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Infection Complicated With Functional Dyspepsia
NCT06340724Phase 3Completed
- Sponsor
- Nanjing First Hospital
- Start
- Feb 2024
- Primary completion
- Nov 2024
- Modality
- Herbal Formulation
- Countries
- 1
01
Overview
A Phase 3 trial of Banxia Xiexin Decoction in Helicobacter pylori infection, functional dyspepsia (FD), sponsored by Nanjing First Hospital. Started Feb 2024; status: completed.
02
Drugs
Banxia Xiexin Decoction
03
Conditions
Helicobacter pylori infectionfunctional dyspepsia (FD)
Beyond the preview
Go deeper on NCT06340724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06340724.